Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 6, 2011, Pages 1827-1834

  Puurunen, Johanna ^a   Piltonen, Terhi ^a   Morin Papunen, Laure ^a   Perheentupa, Antti ^b   Järvelä, Ilkka ^a   Ruokonen, Aimo ^a   Tapanainen, Juha S ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; C REACTIVE PROTEIN; CHORIONIC GONADOTROPIN; INSULIN; SEX HORMONE;

ADULT; ANDROGEN RELEASE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOCRINE DISEASE; FEMALE; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN RESPONSE; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY COMPOSITION; CHORIONIC GONADOTROPIN; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICLE STIMULATING HORMONE; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INHIBINS; LUTEINIZING HORMONE; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; POSTMENOPAUSE; SEX HORMONE-BINDING GLOBULIN;

EID: 79956321806     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2011-0039     Document Type: Article

References (40)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749 (Pubitemid 38766360)
2. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ 2010 The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25:544-551
3. Moran LJ, Misso ML, Wild RA, Norman RJ 2010 Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16:347-363
4. Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG 2008 Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod 23:2352-2358
5. Rosenfield RL 1999 Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am 28:265-293 (Pubitemid 29242714)
6. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84: 165-169 (Pubitemid 29036695)
7. Legro RS, Kunselman AR, Dunaif A 2001 Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111:607-613 (Pubitemid 34088070)
8. Qu J, Wang Y, Wu X, Gao L, Hou L, Erkkola R 2009 Insulin resistance directly contributes to androgenic potential within ovarian theca cells. Fertil Steril 91(Suppl 5):1990-1997
9. Zhao L, Li W, Han F, Hou L, Baillargeon JP, Kuang H, Wang Y, Wu X 2011 Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. Fertil Steril 95:461-463
10. Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar- Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA 2010 Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab 95: 2038-2049
11. Orio Jr F, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanovà L, Nardo LG, Labella D, Savastano S, Russo T, Zullo F, Colao A, Lombardi G 2005 The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 90:2-5 (Pubitemid 40116624)
12. Wild S, Pierpoint T, McKeigue P, Jacobs H 2000 Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52:595-600 (Pubitemid 30337085)
13. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ 2008 Postmenopausalwomenwith a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93:1276-1284 (Pubitemid 351519721)
14. Patel SM, Ratcliffe SJ, Reilly MP, Weinstein R, Bhasin S, Blackman MR, Cauley JA, Sutton-Tyrrell K, Robbins J, Fried LP, Cappola AR 2009 Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 94:4776-4784
15. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL 2000 A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85: 2832-2838 (Pubitemid 32269161)
16. Burger HG, Hale GE, Robertson DM, Dennerstein L 2007 A review of hormonal changes during the menopausal transition: Focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 13:559-565 (Pubitemid 350018524)
17. Khaw KT, Barrett-Connor E 1991 Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women. Clin Sci (Lond) 80:199-203
18. Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, Chandler WL, Boyko EJ, Brunzell JD 2009 Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 94:1104-1110
19. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, Sutton-Tyrrell K 2009 Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 54:2366-2373
20. Piltonen T, Koivunen R, Ruokonen A, Tapanainen JS 2003 Ovarian age-related responsiveness to human chorionic gonadotropin. J Clin Endocrinol Metab 88:3327-3332 (Pubitemid 36877512)
21. Piltonen T, Koivunen R, Perheentupa A, Morin-Papunen L, Ruokonen A, Tapanainen JS 2004 Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:3769-3775 (Pubitemid 39071470)
22. Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS 2009 Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. J Clin Endocrinol Metab 94:1973-1978
23. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
24. Homburg R, Giudice LC, Chang RJ 1996 Polycystic ovary syndrome. Hum Reprod 11:465-466 (Pubitemid 26125240)
25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
26. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553 (Pubitemid 28319935)
27. Legro RS, Finegood D, Dunaif A 1998 A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694-2698 (Pubitemid 28493762)
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
29. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
30. Carmina E, Lobo RA 2004 Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 82:661-665 (Pubitemid 39243189)
31. Svendsen PF, Nilas L, Nørgaard K, Jensen JE, Madsbad S 2008 Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod 23:2113-2121
32. Yildiz BO, Knochenhauer ES, Azziz R 2008 Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab 93: 162-168
33. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174 (Pubitemid 19250404)
34. Taponen S, Martikainen H, Järvelin MR, Sovio U, Laitinen J, Pouta A, Hartikainen AL, McCarthy MI, Franks S, Paldanius M, Ruokonen A; Northern Finland Birth Cohort 1966 Study 2004 Metabolic cardiovascular disease risk factors inwomenwith self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. J Clin Endocrinol Metab 89:2114-2118
35. Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Tapanainen JS 2000 Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthywomenandwomenwith polycystic ovarian syndrome. Hum Reprod 15:1266-1274 (Pubitemid 30335948)
36. Boudreaux MY, Talbott EO, Kip KE, Brooks MM, Witchel SF 2006 Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up. Curr Diab Rep 6:77-83
37. Spencer JB, Klein M, Kumar A, Azziz R 2007 The age-associated decline of androgens in reproductive age and menopausal black and white women. J Clin Endocrinol Metab 92:4730-4733 (Pubitemid 350223451)
38. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S 2009 Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361:1152-1163
39. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N 2001 Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 86:2453-2455 (Pubitemid 32545690)
40. Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, Blumenfeld Z 2004 Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 89:2160-2165 (Pubitemid 38619847)